Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

transcreation

A Deep-Dive into the COVID-19 Pandemic and its Secondary Effects

Dr. Farah Fourcand, Author of Pandemic Manifesto, shares her experience working on the frontlines of the COVID-19 pandemic. She also dives into the psychological impact of COVID-19, lessons learned from the...

Impetus Digital

- PMLiVE

Lilly signs $960m deal with Rigel to develop RIPK1 inhibitors

Companies will co-develop molecules for the treatment of immunological and neurodegenerative diseases

- PMLiVE

10 Top Tips to Optimise Your Virtual Conference

A virtual conference is a live digital event, built around an agenda to replicate an in-person event. In this blog, Digital Engagement Manager Laura Smith shares her 10 top tips...

IGNIFI

- PMLiVE

AZ/Merck & Co’s PARP inhibitor Lynparza scores trial win in early breast cancer

Trial halted early after crossing superiority boundary for the primary endpoint of invasive disease-free survival

EU flag

Pfizer/BioNTech and Moderna increase COVID-19 vaccine supplies to the EU

The EU now currently has access to 2.6 billion COVID-19 vaccine doses from a range of companies

- PMLiVE

The print edition of T40 2020 is available now!

The print edition contains exclusive results analysis and is easy to download

- PMLiVE

South African variant reduces antibody levels produced by Pifzer/BioNTech’s COVID-19 vaccine

Researchers noted it is 'unclear' what effect this reduction has on the vaccine's protection against the variant

- PMLiVE

akt health communications hires Heather Tarplee as senior account director

Prior to joining akt health, Tarplee worked at Freuds for five years

- PMLiVE

AI and accelerated computing ring in new era for healthcare

The AI trends set to dominate healthcare in 2021

- PMLiVE

HCA releases new PR media guide

The guide aims to help healthcare PR professionals understand how best to approach journalists

- PMLiVE

Novartis partners with Bill & Melinda Gates Foundation on ‘accessible’ sickle cell gene therapy

Project will aim to discover and develop a gene therapy for sickle cell disease

Pandemics for dummies

The mistakes are plentiful, but one stands out as most egregious

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links